Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01148498
Show Display Options
Rank Status Study
1 Completed A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's
Condition: Alzheimer's Disease
Intervention: Drug: solanezumab

Study has passed its completion date and status has not been verified in more than two years.